SPDR S&P Biotech ETF Sees Unusually High Options Volume (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) was the recipient of some unusual options trading activity on Friday. Traders acquired 73,593 put options on the stock. This is an increase of 25% compared to the average daily volume of 58,703 put options.

Institutional Investors Weigh In On SPDR S&P Biotech ETF

Several large investors have recently bought and sold shares of XBI. Synovus Financial Corp boosted its position in SPDR S&P Biotech ETF by 110.9% during the third quarter. Synovus Financial Corp now owns 9,391 shares of the exchange traded fund’s stock worth $928,000 after acquiring an additional 4,939 shares during the last quarter. Sanctuary Advisors LLC lifted its stake in SPDR S&P Biotech ETF by 12.7% in the 3rd quarter. Sanctuary Advisors LLC now owns 15,166 shares of the exchange traded fund’s stock worth $1,460,000 after purchasing an additional 1,711 shares in the last quarter. Pine Valley Investments Ltd Liability Co boosted its holdings in shares of SPDR S&P Biotech ETF by 33.0% during the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 10,387 shares of the exchange traded fund’s stock worth $1,026,000 after purchasing an additional 2,577 shares during the last quarter. Westside Investment Management Inc. grew its position in shares of SPDR S&P Biotech ETF by 3.4% in the third quarter. Westside Investment Management Inc. now owns 6,170 shares of the exchange traded fund’s stock valued at $610,000 after purchasing an additional 200 shares in the last quarter. Finally, Invst LLC increased its holdings in shares of SPDR S&P Biotech ETF by 6.0% in the third quarter. Invst LLC now owns 2,807 shares of the exchange traded fund’s stock valued at $277,000 after purchasing an additional 160 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $93.40 on Friday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The company has a market cap of $7.12 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock has a 50 day simple moving average of $98.05 and a 200-day simple moving average of $97.01.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.